Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Masimo Corp Stock Research

MASI

84.63USD-3.08(-3.51%)Market Closed
Watchlist

Market Summary

USD84.63-3.08
Market Closed
-3.51%

MASI Alerts

  • Big fall in Revenue (Y/Y)

MASI Stock Price

MASI RSI Chart

MASI Valuation

Market Cap

4.6B

Price/Earnings (Trailing)

39.99

Price/Sales (Trailing)

2.12

EV/EBITDA

16.83

Price/Free Cashflow

-300.72

MASI Price/Sales (Trailing)

MASI Profitability

EBT Margin

6.99%

Return on Equity

8.89%

Return on Assets

3.79%

Free Cashflow Yield

-0.33%

MASI Fundamentals

MASI Revenue

Revenue (TTM)

2.2B

Revenue Y/Y

-19.46%

Revenue Q/Q

-19.42%

MASI Earnings

Earnings (TTM)

115.8M

Earnings Y/Y

-13.26%

Earnings Q/Q

-26.29%

Price Action

52 Week Range

83.03198.00
(Low)(High)

Last 7 days

-4.0%

Last 30 days

-22.8%

Last 90 days

-45.5%

Trailing 12 Months

-37.9%

MASI Financial Health

Current Ratio

2.16

MASI Investor Care

Buy Backs (1Y)

2.04%

Diluted EPS (TTM)

2.13

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for MASI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-26
Cohen H Michael
acquired
-
-
1,435
-
2023-05-26
Mikkelson Adam
acquired
-
-
1,435
-
2023-05-26
Shimer Julie Ann
acquired
-
-
1,435
-
2023-05-26
REYNOLDS CRAIG B
acquired
-
-
1,435
-
2023-05-25
KIANI JOE E
bought
1,000,340
157
6,365
ceo and chairman of the board
2023-03-17
KIANI JOE E
gifted
-
-
42,735
ceo and chairman of the board
2023-03-17
KIANI JOE E
gifted
-
-
-42,735
ceo and chairman of the board
2023-03-03
Young Micah W
sold (taxes)
-485,811
182
-2,663
evp & chief financial officer
2023-03-03
KIANI JOE E
sold (taxes)
-4,817,980
182
-26,410
ceo and chairman of the board
2023-03-03
Muhsin Bilal
sold (taxes)
-967,244
182
-5,302
chief operating officer

1–10 of 50

Which funds bought or sold MASI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-26
BROOKFIELD Corp /ON/
added
21.76
320,290
4,056,490
0.02%
2023-09-21
Jefferies Group LLC
new
-
276,673
276,673
-%
2023-09-20
BARCLAYS PLC
added
12.66
37,000
8,055,000
-%
2023-09-12
Farther Finance Advisors, LLC
added
28.21
1,031
8,228
-%
2023-08-24
Alberta Investment Management Corp
sold off
-100
-202,994
-
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
sold off
-100
-1,093,950
-
-%
2023-08-21
OSAIC HOLDINGS, INC.
reduced
-20.7
-513,026
1,235,770
-%
2023-08-21
VitalStone Financial, LLC
unchanged
-
-65,000
110,000
0.06%
2023-08-21
BOKF, NA
sold off
-100
-5,905
-
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-11.78
-3,246,380
11,969,900
0.02%

1–10 of 44

Latest Funds Activity

Are funds buying MASI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MASI
No. of Funds

Schedule 13G FIlings of Masimo

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jun 30, 2023
politan capital management lp
8.9%
4,713,518
SC 13D/A
May 01, 2023
politan capital management lp
9.0%
4,713,518
SC 13D/A
Mar 13, 2023
politan capital management lp
9.0%
4,739,963
SC 13D/A
Mar 06, 2023
politan capital management lp
9.0%
4,739,963
SC 13D/A
Feb 14, 2023
kiani joe e
9.3%
4,975,021
SC 13G/A
Feb 09, 2023
vanguard group inc
9.24%
4,855,501
SC 13G/A
Jan 26, 2023
blackrock inc.
11.3%
5,956,832
SC 13G/A
Jan 20, 2023
blackrock inc.
11.3%
5,956,832
SC 13G/A
Jan 10, 2023
fmr llc
-
0
SC 13G
Oct 21, 2022
politan capital management lp
8.8%
4,648,869
SC 13D/A

Recent SEC filings of Masimo

View All Filings
Date Filed Form Type Document
Aug 11, 2023
4/A
Insider Trading
Aug 10, 2023
4
Insider Trading
Aug 08, 2023
8-K
Current Report
Aug 08, 2023
3
Insider Trading
Aug 08, 2023
10-Q
Quarterly Report
Jul 17, 2023
8-K
Current Report
Jul 06, 2023
4
Insider Trading
Jul 06, 2023
3
Insider Trading
Jun 30, 2023
SC 13D/A
13D - Major Acquisition
Jun 29, 2023
4
Insider Trading

Peers (Alternatives to Masimo)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
103.6B
6.7B
-4.97% 57.37%
72.72
15.55
11.75% -0.66%
103.5B
31.6B
-5.31% -3.69%
28.53
3.28
1.57% -30.40%
42.1B
5.7B
-9.43% -16.28%
30.27
7.43
5.64% -4.53%
22.9B
3.7B
-20.04% 44.73%
73.04
6.14
-6.33% -49.26%
17.0B
4.0B
-8.32% 6.74%
35.13
4.21
-22.73% -67.98%
MID-CAP
9.1B
937.8M
-9.65% 25.86%
313.94
9.75
16.30% 250.21%
4.5B
2.6B
-14.85% -15.97%
20.83
1.75
1.78% -15.77%
3.0B
1.1B
-10.10% 23.89%
34.49
2.67
9.28% 177.49%
2.8B
1.1B
-5.71% 3.72%
-29.18
2.61
6.60% -233.50%
1.7B
151.1M
-23.64% 26.45%
-96.88
11.38
193.70% 62.80%
SMALL-CAP
1.2B
177.1M
-23.71% -16.88%
-19.22
6.6
23.02% 15.37%
945.1M
780.7M
-5.83% -7.35%
-26.25
1.21
4.68% -510.17%
583.4M
162.2M
0.22% -40.97%
-6.94
3.6
9.71% 12.37%
120.1M
349.3M
-16.18% -78.67%
-1.25
0.34
-1.13% -239.54%
21.3M
414.9M
-67.24% -82.21%
-0.26
0.05
-23.37% 16.91%

Masimo News

Digital Journal
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ....
Digital Journal,
2 hours ago
Stockhouse Publishing
Morningstar

Returns for MASI

Cumulative Returns on MASI

12.6%


10-Year Cumulative Returns

5.6%


7-Year Cumulative Returns

-6.4%


5-Year Cumulative Returns

-27.9%


3-Year Cumulative Returns

Risks for MASI

What is the probability of a big loss on MASI?

48.1%


Probability that Masimo stock will be more than 20% underwater in next one year

25.4%


Probability that Masimo stock will be more than 30% underwater in next one year.

24.2%


Probability that Masimo stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MASI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Masimo was unfortunately bought at previous high price.

Drawdowns

Financials for Masimo

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue-4.8%2,1872,2972,0361,7461,5041,2441,2391,2071,1771,1731,1441,0961,047976938913895877858843826
Gross Profit-3.2%1,1021,1391,059960881816808780756754743723700663629611595583575565549
Operating Expenses-4.6%907951849746655546533517500502487471456429408397384373367366355
  S&GA Expenses-4.9%708745657576502408395381371376369361351330315306297289285287281
  R&D Expenses-3.7%19820619117015313913713612912611911010699.0093.0091.0087.0083.0081.0080.0074.00
EBITDA-100.0%-314330280328305310299289288293289280271258248243239235226224
EBITDA Margin-100.0%-0.14*0.16*0.16*0.22*0.25*0.25*0.25*0.25*0.25*0.26*0.26*0.27*0.28*0.27*0.27*0.27*0.27*0.27*0.26*0.27*
Earnings Before Taxes-1.1%159161193214230269274264258256264261255247234225221218214204197
EBT Margin-100.0%-0.07*0.10*0.12*0.15*0.22*0.22*0.22*0.22*0.22*0.23*0.24*0.24*0.25*0.25*0.25*0.25*0.25*0.25*0.24*0.24*
Net Income-2.0%116118144171191223230232224229240223222211196190198197194139118
Net Income Margin-100.0%-0.05*0.07*0.10*0.13*0.18*0.19*0.19*0.19*0.20*0.21*0.20*0.21*0.22*0.21*0.21*0.22*0.22*0.23*0.16*0.14*
Free Cashflow100.0%--34.20-23.4093.00164192239198155183138144155123153154157190222207155
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-3.3%3,0113,1163,2113,0562,9611,9091,8871,7671,6821,5981,7131,7131,6361,4751,3961,3141,2301,1791,1551,0961,007
  Current Assets-4.2%1,2081,2611,3091,2461,1581,2251,2391,1381,0529831,1011,1591,093980996934864850789736654
    Cash Equivalents-13.4%151174203220218720748652576552641669632606568513409413553493430
  Inventory7.8%54350450149544921320120220721621620515511611611099.0093.0095.0093.0091.00
  Net PPE2.0%410402403372371300273275275275273267263253220209203167166165164
  Goodwill-2.6%41142244544643532610010110210210380.0079.0054.0022.0022.0022.0022.0023.0023.0020.00
Liabilities-4.6%1,7031,7851,8721,8041,758327337299290270305298291221228206190174186183182
  Current Liabilities-1.9%572583630587552254268228220197234233228157172150136121147144129
    LT Debt, Non Current-1.0%889898942951922----------------
Shareholder's Equity-1.7%1,3081,3301,3391,2531,2031,5821,5501,4681,3911,3281,4081,4151,3451,2531,1681,1081,0401,005969912825
  Retained Earnings0.9%1,7511,7361,7141,6741,6361,6171,5711,5031,4451,3951,3411,2711,2211,1651,1001,048998954931884827
  Additional Paid-In Capital-1.0%774782782775759741753737714703704677658624601585565547533523493
Shares Outstanding0%53.0053.0053.0053.0054.0055.0055.0055.0055.0055.0055.0055.0055.0054.0054.0054.0053.0053.0053.0052.0052.00
Minority Interest------------0.02----------
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations321.2%28.007.0029.00134205229265232190228211217227222222215212210240225199
  Share Based Compensation-58.7%18.0044.0048.0053.0052.0043.0045.0039.0039.0044.0042.0046.0045.0043.0039.0037.0034.0029.0027.0026.0023.00
Cashflow From Investing93.9%-64.00-1,044-1,057-1,040-1,047-50.92-37.50-33.46-29.35-77.89-82.80-94.30-38.98-25.07-197-189-242-206-26.15-27.28-50.89
Cashflow From Financing-103.1%-15.50507520529510-4.75-122-219-223-205-54.3035.0038.00-4.25-9.34-3.2110.0042.0026.006.00-51.15
  Buy Backs-0.00-402401401-0.0212923923923911110.0010.0038.0038.0028.0028.000.0018.0042.0085.00

MASI Income Statement

2023-07-01
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Jul. 01, 2023
Jul. 02, 2022
Jul. 01, 2023
Jul. 02, 2022
Income Statement [Abstract]    
Revenue$ 455.3$ 565.3$ 1,020.3$ 869.5
Cost of goods sold234.1307.1514.3406.6
Gross profit221.2258.2506.0462.9
Operating expenses:    
Selling, general and administrative151.7188.3348.0297.2
Research and development40.247.890.783.9
Total operating expenses191.9236.1438.7381.1
Operating income29.322.167.381.8
Non-operating (loss) income(4.5)4.5(16.3)3.9
Income before provision for income taxes24.826.651.085.7
Provision for income taxes9.18.514.021.0
Net income$ 15.7$ 18.1$ 37.0$ 64.7
Net income per share:    
Basic (in dollars per share)$ 0.30$ 0.34$ 0.70$ 1.18
Diluted (in dollars per share)$ 0.29$ 0.33$ 0.68$ 1.15
Weighted-average shares used in per share calculations:    
Basic (in shares)52.853.952.754.7
Diluted (in shares)54.455.354.356.4

MASI Balance Sheet

2023-07-01
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jul. 01, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 150.7$ 202.9
Trade accounts receivable, net of allowance for credit losses of $11.8 million and $7.7 million at July 1, 2023 and December 31, 2022, respectively348.8445.9
Inventories542.6501.0
Other current assets166.1158.8
Total current assets1,208.21,308.6
Lease receivable, non-current77.573.1
Deferred costs and other contract assets42.341.9
Property and equipment, net410.0402.5
Intangible assets, net426.5460.6
Trademarks - (Note 9)239.2262.0
Goodwill410.9445.4
Deferred tax assets88.4102.5
Other non-current assets108.2114.0
Total assets3,011.23,210.6
Current liabilities  
Accounts payable265.5276.8
Accrued compensation50.289.3
Deferred revenue and other contract liabilities, current73.780.6
Other current liabilities182.5183.3
Total current liabilities571.9630.0
Long-term debt888.8941.6
Deferred tax liabilities118.9163.6
Other non-current liabilities123.3136.5
Total liabilities1,702.91,871.7
Commitments and contingencies - (Note 24)
Stockholders’ equity  
Preferred stock, $0.001 par value; 5.0 million shares authorized; 0 shares issued and outstanding0.00.0
Common stock, $0.001 par value; 100.0 million shares authorized; 52.8 million and 52.5 million shares issued and outstanding at July 1, 2023 and December 31, 2022, respectively0.10.1
Treasury stock, 19.5 million and 19.5 million shares at July 1, 2023 and December 31, 2022, respectively(1,169.2)(1,169.2)
Additional paid-in capital773.7782.2
Accumulated other comprehensive (loss) income(47.6)11.5
Retained earnings1,751.31,714.3
Total stockholders’ equity1,308.31,338.9
Total liabilities and stockholders’ equity3,011.23,210.6
Customer relationships  
Current assets  
Intangible assets, net182.0201.6
Acquired technologies  
Current assets  
Intangible assets, net144.3160.1
Other intangible assets, net  
Current assets  
Intangible assets, net$ 100.2$ 98.9
Joe E. Kiani
6200
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.